2m 2m 2m 2m 2m 2m 2m
PRECIGEN (PGEN)
NASDAQ
$5.29-$0.09 (-1.67%)
Price as of Jun 23, 2026 6:48 PM EDT- $1.9BMarket Cap
- 263.51%1-Year Change
- BiotechnologyIndustry
PRECIGEN (PGEN)
$5.29-$0.09 (-1.67%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.8M N/A | 0 -100.00% | 25.1M -6.91% | 26.9M -74.09% | |
Cost of Revenue | 4.8M +13.03% | 4.3M -30.27% | 6.1M -3.47% | 6.3M -89.14% | |
Gross Profit | -3.0M -29.58% | -4.3M -122.54% | 18.9M -7.97% | 20.6M +27,165.79% | |
Sales and Marketing Expense | 70.1M +69.83% | 41.3M +2.17% | 40.4M -15.81% | 48.0M -35.23% | |
Research and Development Expense | -41.3M -22.12% | -53.1M +9.17% | -48.6M +3.06% | -47.2M -5.93% | |
Depreciation and Amortization Expense | 3.2M -29.32% | 4.5M -32.12% | 6.7M -38.06% | 10.8M -21.77% | |
Total Operating Expenses | 120.2M -13.50% | 139.0M +31.11% | 106.0M +3.26% | 102.6M -43.97% | |
Operating Profit | -110.5M -18.16% | -135.0M +35.36% | -99.8M +31.74% | -75.7M -4.53% | |
Interest Income | 3.2M +126.73% | 1.4M -78.10% | 6.5M +4,767.67% | 133,000 -91.77% | |
Interest Expense | -3.9M +745.95% | -457,000 -51.18% | -936,000 -93.09% | -13.5M -64.14% | |
Interest Income and Expense and Net | -651,000 -167.74% | 961,000 -82.65% | 5.5M +141.28% | -13.4M -62.91% | |
Total Nonoperating Income and Expense | -140.1M -2,101.60% | 7.0M +106.15% | 3.4M +166.56% | -5.1M -71.02% | |
Income before Taxes | -250.6M +95.77% | -128.0M +32.86% | -96.4M +20.50% | -80.0M -17.50% | |
Income Taxes | 3,000 +100.17% | -1.8M +291.48% | -458,000 +142.33% | -189,000 +18.13% | |
Extraordinary Items | N/A N/A | 40.3M +272.16% | 10.8M N/A | 0 -100.00% | |
Net Income | -250.6M +98.55% | -126.2M +31.63% | -95.9M -438.68% | 28.3M +130.72% | |
Net Income from Continuing Operations Applicable to Common | -429.6M +235.58% | -128.0M +32.86% | -96.4M +20.50% | -80.0M -17.36% | |
Basic EPS and Net Income | -1.37 +191.49% | -0.47 +20.51% | -0.39 -378.57% | 0.14 +129.79% | |
Diluted EPS and Net Income | -1.37 +191.49% | -0.47 +20.51% | -0.39 -378.57% | 0.14 +129.79% | |
Basic Weighted Average Shares | 313.0M +16.90% | 267.7M +9.48% | 244.5M +22.05% | 200.4M +1.32% | |
Diluted Weighted Average Shares | 313.0M +16.90% | 267.7M +9.48% | 244.5M +22.05% | 200.4M +1.32% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 30.2M +2.43% | 29.5M +289.51% | 7.6M +55.99% | 4.9M -88.68% | |
Short-Term Investments | 67.6M -1.12% | 68.4M +23.73% | 55.3M +8.19% | 51.1M -29.27% | |
Cash and Cash Equivalents and Short-Term Investments | 97.9M -0.05% | 97.9M +55.77% | 62.9M +12.34% | 56.0M -51.42% | |
Total Current Assets | 115.2M +12.52% | 102.4M +48.95% | 68.8M -41.81% | 118.2M -24.56% | |
Accumulated Depreciation | 23.8M +4.16% | 22.9M -5.81% | 24.3M +3.60% | 23.4M -40.24% | |
Property and Plant and Equipment and Net | 13.8M -0.53% | 13.8M +94.50% | 7.1M -2.97% | 7.3M -78.64% | |
Total Long-Term Assets | 908,000 +144.74% | 371,000 -51.63% | 767,000 -25.17% | 1.0M -13.72% | |
Total Assets | 155.5M +7.05% | 145.3M -3.82% | 151.0M -30.07% | 216.0M -39.98% | |
Income Taxes Payable | N/A N/A | 0 -100.00% | 1.8M -18.38% | 2.3M -10.87% | |
Total Short-Term Debt | 0 N/A | 0 N/A | 0 -100.00% | 43.2M +9,974.36% | |
Total Current Liabilities | 37.3M +73.37% | 21.5M -6.38% | 23.0M -70.77% | 78.6M +127.00% | |
Total Long-Term Debt | 93.2M N/A | N/A N/A | 43.2M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 134,000 -97.93% | 6.5M -43.19% | 11.4M -14.46% | 13.3M +26,572.00% | |
Total Liabilities | 134.6M +71.38% | 78.5M +141.31% | 32.5M -63.73% | 89.7M -64.47% | |
Retained Earnings | -2.3B +11.99% | -2.1B +6.43% | -2.0B +5.13% | -1.9B -2.45% | |
Total Stockholders Equity | 20.9M -45.70% | 38.5M -67.50% | 118.5M -6.15% | 126.3M +17.62% | |
Total Shares Outstanding | 353.9M +230.35% | 107.1M -56.96% | 248.9M +19.59% | 208.2M +0.68% | |
Cash Flow | |||||
Cash from Operating Activities | -87.8M +28.84% | -68.2M +1.86% | -66.9M +2.90% | -65.0M +16.63% | |
Capital Expenditures | 2.0M -76.76% | 8.6M +458.85% | 1.5M -68.81% | 4.9M -32.05% | |
Cash from Investing Activities | -1.5M -92.59% | -20.7M +571.01% | -3.1M -101.36% | 226.4M +403.75% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 90.0M -18.57% | 110.6M +273.73% | 29.6M +119.05% | -155.3M -228.14% | |
Financials Ratio | |||||
Gross Margin | -165.29% N/A | N/A N/A | 75.57% -1.14% | 76.44% +74.56% | |
Operating Margin | -6,078.49% N/A | N/A N/A | -398.24% +41.51% | -281.42% +268.53% | |
Return on Assets | -166.67% +95.61% | -85.20% +63.04% | -52.26% -631.37% | 9.84% +135.99% | |
Return on Equity | -843.57% +424.62% | -160.80% +105.19% | -78.37% -423.25% | 24.24% +122.95% | |
Revenue Growth | N/A N/A | -100.00% +1,347.49% | -6.91% -90.68% | -74.09% -11,099.75% | |
Current Ratio | 3.09 -35.10% | 4.76 +59.11% | 2.99 +99.10% | 1.50 -66.77% | |
Cash Ratio | 0.81 -40.92% | 1.37 +316.04% | 0.33 +433.50% | 0.06 -95.01% | |
Debt-to-Equity Ratio | 4.46 N/A | N/A N/A | 0.36 +6.54% | 0.34 -79.94% | |
Debt-to-Assets Ratio | 0.60 N/A | N/A N/A | 0.29 +42.98% | 0.20 -60.69% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow